. Western blots of cell extracts from a human fibroblast cell line that was exposed to a protein farnesyltransferase inhibitor (ABT-100, 0.5 µM) or lopinavir (20 µM) for three days. The cell extracts were size-fractionated on 4-12% polyacrylamide-SDS gels and proteins were transferred to nitrocellulose membranes for western blotting. Membranes were cut in half; the bottom half was incubated with a goat IgG against actin (as a loading control); the top half was incubated with either a goat IgG against human lamin A/C (panel A) or a rat monoclonal antibody against prelamin A (panel B) (monoclonal antibody 7G11; created by immunizing a rat with a synthetic peptide corresponding to the last 15 amino acids of mouse prelamin A)
1 . In the case of mouse prelamin A, monoclonal antibody 7G11 detects both farnesylated and nonfarnesylated prelamin A. However, for human prelamin A, the antibody is specific for nonfarnesylated prelamin A. Binding of the primary antibodies was detected by incubating the membranes with an IRDye-conjugated donkey anti-goat IgG or an IRDye-conjugated donkey anti-rat IgG; bands were visualized with the Odyssey Infrared Imaging System (Li-Cor Biosciences). An accumulation of prelamin A is clearly observed in the presence of both the protein farnesyltransferase inhibitor and lopinavir. Note that the nonfarnesylated prelamin A in the protein farnesyltransferase-treated fibroblasts has a slower electrophoretic mobility than the farnesyl-prelamin A in lopinavir-treated cells. Figure S2 . Amino acid sequences and molecular weights of substrate petide and their respective products. Figure S3 . Mass spectra of the farnesylated substrate peptide after inubation with the wild-type (a) and the mutant E336A ZMPSTE24 (b). When incubated with the wild-type protein, a decrease in the intensity of the substrate peptide and an increased instensity of cleaved product is evident with time. In the case of mutant ZMPSTE24, the substrate peptide remains undigested. Upper panel shows the control (i.e., substrate peptide without any ZMPSTE24). Figure S4 . Mass spectra of the nonfarnesylated 14-mer peptide. The substrate remains essentially uncleaved after 10-12' and only modestly cleaved after a 1-h incubation. (C) Figure S8 . Collision-induced unfolding profile of the 11+ charge state of ZMPSTE24. The ions remain native-like under low activation conditions. A long-lived unfolded state is formed at a collision voltage of 75 V and eventually transitions to a more unfolded form of the protein beyond 140 V.
